NGM Biopharmaceuticals
A biopharmaceutical company developing therapeutics for the treatment of cardio-metabolic and liver diseases
2
Funding Rounds
$74.6m
Money raised
Overview
A biopharmaceutical company developing therapeutics for the treatment of cardio-metabolic and liver diseases
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Wi J. Ri | - | - | - |
| Da*** V. Go | - | - | - |
| Ji* Ch** | - | - | - |
| Da*** J. Wo** | - | - | |
| Ro*** M. Pe*** | - | - | - |
| Ca**** Ho | - | - | |
| Su Sa* Ho**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company NGM Biopharmaceuticals has raised a total of $74.55m in funding over 2 rounds.
Key Insights:
- NGM Biopharmaceuticals Series C round: $50m
- NGM Biopharmaceuticals Series A round: $24.55m
NGM Biopharmaceuticals Series C round
$50m
NGM Biopharmaceuticals Series A round
$24.55m
Industries
NGM Biopharmaceuticals is active in the following industries: